The DOI matches its Crossref record; 304 of the 304 references it cites were found in a registry or an index.
Nuclear receptors as therapeutic targets in cholestatic liver diseases
Open accessAbstract
Cholestasis results in intrahepatic accumulation of cytotoxic bile acids, which cause liver damage ultimately leading to biliary fibrosis and cirrhosis. Cholestatic liver injury is counteracted by a variety of adaptive hepatoprotective mechanisms including alterations in bile acid transport, synthesis and detoxification. The underlying molecular mechanisms are mediated mainly at a transcriptional level via a complex network involving nuclear receptors including the farnesoid X receptor, pregnane X receptor, vitamin D receptor and constitutive androstane receptor, which target overlapping, although not identical, sets of genes. Because the intrinsic adaptive response to bile acids cannot fully prevent liver injury in cholestasis, therapeutic targeting of these receptors via specific and potent agonists may further enhance the hepatic defence against toxic bile acids. Activation of these receptors results in repression of bile acid synthesis, induction of phases I and II bile acid hydroxylation and conjugation and stimulation of alternative bile acid export while limiting hepatocellular bile acid import. Furthermore, the use of nuclear receptor ligands may not only influence bile acid transport and metabolism but may also directly target hepatic fibrogenesis and inflammation. Many drugs already used to treat cholestasis and its complications such as pruritus (e.g. ursodeoxycholic acid, rifampicin, fibrates) may act via activation of nuclear receptors. More specific and potent nuclear receptor ligands are currently being developed. This article will review the current knowledge on nuclear receptors and their potential role in the treatment of cholestatic liver diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nuclear receptors are ligand-activated transcription factors that regulate gene expression of a variety of key molecular signals involved in liver fibrosis.”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [25]
In the citing paper
“All NRs share a common structure which allows them to bind directly to DNA and regulate gene transcription.[25]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [25]
In the citing paper
“NRs in general, play a pivotal role in the overall control of several biological processes and represent a promising target in liver diseases.[25]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [25]
In the citing paper
“In addition to FXR also other NRs such as the pregnane X receptor (PXR/NR1I2), the constitutive androstane receptor (CAR/NR1I3) and the vitamin D receptor (NR1I1) are activated via certain BAs.45”
From Novel therapeutic targets for cholestatic and fatty liver disease (2022) · cites this paper as [45]
In the citing paper
“pharmacological activation of FXR restores BA homoeostasis by stimulation of transcription of the bile salt export pump that mediates the rate-limiting step in hepatocellular BA excretion across the canalicular membrane. Together with a reduction of BA uptake systems Na +- taurocholate cotransporting polypeptide (NTCP) and synthesis (CYP7A1) as well as stimulation of alternative basolateral export”
From Novel therapeutic targets for cholestatic and fatty liver disease (2022) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The RXR heterodimers and orphan receptors
Mangelsdorf, D. J., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90200-7 · Cited by 3,165
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Nuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
Nuclear Receptor Coregulators: Cellular and Molecular Biology
McKenna, N. J., Lanz, R. B., & O’Malley, B. W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0366 · Cited by 1,941
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819
The PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816
Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3)
Yamagata, K., Oda, N., Kaisaki, P. J., Menzel, S., Furuta, H., Vaxillaire, M., Southam, L., Cox, R., Lathrop, M. G., Boriraj, V. V., et al. (1996) · Nature · doi:10.1038/384455a0 · Cited by 1,614
Lee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594
An oxysterol signalling pathway mediated by the nuclear receptor LXRα
Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., & Mangelsdorf, D. J. (1996) · Nature · doi:10.1038/383728a0 · Cited by 1,591
Lehmann, J., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., & Kliewer, S. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3703 · Cited by 1,577
Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors
Lu, T. T., Makishima, M., Repa, J. J., Schoonjans, K., Kerr, T. A., Auwerx, J., & Mangelsdorf, D. J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00050-2 · Cited by 1,487
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease
Finck, B. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27794 · Cited by 1,461
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Staudinger, J. L., Goodwin, B. J., Jones, S. A., Hawkins‐Brown, D., MacKenzie, K. I., Latour, A. M., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J. F., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051551698 · Cited by 1,378
Control of Pancreas and Liver Gene Expression by HNF Transcription Factors
Odom, D. T., Zizlsperger, N., Gordon, D. B., Bell, G. W., Rinaldi, N. J., Murray, H. L., Volkert, T. L., Schreiber, J., Rolfe, A., Gifford, D. K., et al. (2004) · Science · doi:10.1126/science.1089769 · Cited by 1,348
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2005) · Nature · doi:10.1038/nature03988 · Cited by 1,287
Activation of the Nuclear Receptor LXR by Oxysterols Defines a New Hormone Response Pathway
Lehmann, J. M., Kliewer, S. A., Moore, L. B., Smith-Oliver, T. A., Oliver, B. B., Su, J.-L., Sundseth, S. S., Winegar, D. A., Blanchard, D. E., Spencer, T. A., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3137 · Cited by 1,233
Vitamin D Receptor As an Intestinal Bile Acid Sensor
Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R., & Mangelsdorf, D. J. (2002) · Science · doi:10.1126/science.1070477 · Cited by 1,176
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
Inagaki, T., Moschetta, A., Lee, Y.-K., Peng, L., Zhao, G., Downes, M., Yu, R. T., Shelton, J. M., Richardson, J. A., Repa, J. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509592103 · Cited by 1,164 · cited 2×
“Both NRs also positively regulate basolateral MRP3/Mrp3 expression while only CAR but not PXR ligands induce MRP4/Mrp4 (Cherrington et al., 2002; Guo et al., 2003; Teng et al., 2003; Assem et al., 2004; Zhang et al., 2004a; Maher et al., 2005; Wagner et al., 2005).”
Reciprocal regulation of inflammation and lipid metabolism by liver X receptors
Joseph, S. B., Castrillo, A., Laffitte, B. A., Mangelsdorf, D. J., & Tontonoz, P. (2003) · Nature Medicine · doi:10.1038/nm820 · Cited by 1,158
Sladek, F. M., Zhong, W. M., Lai, E., & Darnell, J. E. (1990) · Genes & Development · doi:10.1101/gad.4.12b.2353 · Cited by 1,027
Bile salt transporters: molecular characterization, function, and regulation
Trauner, M., & Boyer, J. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00027.2002 · Cited by 999
Self-citationStrautnieks, S. S., Bull, L. N., Knisely, A. S., Kocoshis, S. A., Dahl, N., Arnell, H., Sokal, E. M., Dahan, K., Childs, S. J., Ling, V. W. T., et al. (1998) · Nature Genetics · doi:10.1038/3034 · Cited by 988
Liver X receptors as integrators of metabolic and inflammatory signaling
Zelcer, N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27883 · Cited by 978
Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1)
Yamagata, K., Furuta, H., Oda, N., Kaisaki, P. J., Menzel, S., Cox, N. J., Fajans, S. S., Signorini, S. G., Stoffel, M., & Bell, G. I. (1996) · Nature · doi:10.1038/384458a0 · Cited by 975
Kast, H. R., Goodwin, B., Tarr, P. T., Jones, S. A., Anisfeld, A. M., Stoltz, C. M., Tontonoz, P., Kliewer, S., Willson, T. M., & Edwards, P. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109326200 · Cited by 916
Identification of a human nuclear receptor defines a new signaling pathway for CYP 3 A induction
Bertilsson, G., Heidrich, J., Svensson, K., Åsman, M., Jendeberg, L., Sydow‐Báckman, M., OHLSSON, R. I., Postlind, H., Blomquist, P., & Berkenstam, A. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12208 · Cited by 876
Repa, J. J., Berge, K. E., Pomajzl, C., Richardson, J. A., Hobbs, H. H., & Mangelsdorf, D. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109927200 · Cited by 852
Ananthanarayanan, M., Balasubramanian, N., Makishima, M., Mangelsdorf, D. J., & Suchy, F. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011610200 · Cited by 804
Nuclear Receptor Coregulators: Cellular and Molecular Biology
McKenna, N. J. (1999) · Endocrine Reviews · doi:10.1210/er.20.3.321 · Cited by 782
An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids
Xie, W., Radominska-p, A., Shi, Y., Simon, C. M., Nelson, M. C., Ong, E. S., Waxman, D. J., & Evans, R. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051014398 · Cited by 751
Holt, J. A., Luo, G., Billin, A. N., Bisi, J., McNeill, Y. Y., Kozarsky, K., Donahee, M. H., Wang, D. Y., Mansfield, T. A., Kliewer, S. A., et al. (2003) · Genes & Development · doi:10.1101/gad.1083503 · Cited by 714
Molecular Pathogenesis of Cholestasis
Trauner, M., Meier, P. J., & Boyer, J. L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810223391707 · Cited by 711
Self-citationAn overview on biological mechanisms of PPARs
Kota, B. P., Huang, T. H.-W., & Roufogalis, B. D. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2004.07.012 · Cited by 681
Nuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver Regeneration
Huang, W., Ma, K., Zhang, J., Qatanani, M., Cuvillier, J., Liu, J., Dong, B., Huang, X., & Moore, D. D. (2006) · Science · doi:10.1126/science.1121435 · Cited by 645
Molecular Pathogenesis of Cholestasis
Trauner, M., & Jansen, P. L. M. (2004) · Springer eBooks · doi:10.1007/978-1-4419-9034-1 · Cited by 613
Self-citationEnzymology of human cytosolic sulfotransferases
Falany, C. N. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.4.9068609 · Cited by 604
Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine
Kim, I., Ahn, S.-H., Inagaki, T., Choi, M., Ito, S., Guo, G. L., Kliewer, S. A., & Gonzalez, F. J. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700330-jlr200 · Cited by 589
Ghisletti, S., Huang, W., Ogawa, S., Pascual, G., Lin, M.-E., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.11.022 · Cited by 561
Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms
Chiang, J. Y. L. (2003) · Journal of Hepatology · doi:10.1016/j.jhep.2003.11.006 · Cited by 559
Myant, N. B., & Mitropoulos, K. A. (1977) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41693-1 · Cited by 521
Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4α
Hertz, R., Magenheim, J., Berman, I., & Bar‐Tana, J. (1998) · Nature · doi:10.1038/33185 · Cited by 509
Controlling nuclear receptors: the circular logic of cofactor cycles
Perissi, V., & Rosenfeld, M. G. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1680 · Cited by 507
Pineda‐Torra, I., Claudel, T., Duval, C., Kosykh, V., Fruchart, J., & Staels, B. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0120 · Cited by 504
Almé, B., Bremmelgaard, A., Sjövall, J., & Thomassen, P. A. B. (1977) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41684-0 · Cited by 491
Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha.
(2000) · PubMed Central · Cited by 489
Yang, F., Huang, X., Yi, T., Yen, Y., Moore, D. D., & Huang, W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1078 · Cited by 488
Redundant Pathways for Negative Feedback Regulation of Bile Acid Production
Wang, L., Lee, Y., Bundman, D. S., Han, Y., Thevananther, S., Kim, C.-S., Chua, S. S., Wei, P. Y., Heyman, R. A., Karin, M., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00187-9 · Cited by 475
Ou, J., Tu, H., Shan, B., Luk, A. Y., DeBose‐Boyd, R. A., Bashmakov, Y. K., Goldstein, J. L., & Brown, M. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111138698 · Cited by 474
Induction of Drug Metabolism: The Role of Nuclear Receptors
Handschin, C., & Meyer, U. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.2 · Cited by 473
Fiorucci, S., Antonelli, E., Rizzo, G., Renga, B., Mencarelli, A., Riccardi, L., Orlandi, S., Pellicciari, R., & Morelli, A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.001 · Cited by 472
Denson, L. A., Sturm, E., Echevarría, W., Zimmerman, T. L., Makishima, M., Mangelsdorf, D. J., & Karpen, S. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.25503 · Cited by 460
Mammalian hepatocyte differentiation requires the transcription factor HNF-4αPreprint
Li, J., Ning, G., & Duncan, S. A. (2000) · Genes & Development · doi:10.1101/gad.14.4.464 · Cited by 458
LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis.
Fayard, E., Auwerx, J., & Schoonjans, K. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.03.008 · Cited by 445
Galli, A., Crabb, D. W., Ceni, E., Salzano, R., Mello, T., Svegliati–Baroni, G., Ridolfi, F., Trozzi, L., Surrenti, C., & Casini, A. (2002) · Gastroenterology · doi:10.1053/gast.2002.33666 · Cited by 440
The orphan nuclear receptor HNF4α determines PXR- and CAR-mediated xenobiotic induction of CYP3A4
Tirona, R. G., Lee, W., Leake, B. F., Lan, L.-B., Cline, C., Lamba, V., Parviz, F., Duncan, S. A., Inoue, Y., Gonzalez, F. J., et al. (2003) · Nature Medicine · doi:10.1038/nm815 · Cited by 436
King, C., Rios, G. R., Green, M. D., & Tephly, T. R. (2000) · Current Drug Metabolism · doi:10.2174/1389200003339171 · Cited by 432
Shih, D. Q., Bussen, M., Sehayek, E., Ananthanarayanan, M., Shneider, B. L., Suchy, F. J., Shefer, S., Bollileni, J. S., Gonzalez, F. J., Breslow, J. L., et al. (2001) · Nature Genetics · doi:10.1038/86871 · Cited by 422
Krylova, I. N., Sablin, E. P., Moore, J. M. R., Xu, R. X., Waitt, G. M., MacKay, J. A., JUZUMIENE, D. I., Bynum, J. M., Madauss, K. P., Montana, V. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.01.024 · Cited by 409
Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes.
Weinshilboum, R. M., Otterness, D. M., Aksoy, I. A., Wood, T. C., Her, C., & Raftogianis, R. B. (1997) · PubMed · Cited by 408
Regulation of bile acid synthesis
Chiang, J. Y. L. (1998) · Frontiers in bioscience · doi:10.2741/a273 · Cited by 400
Induction of bilirubin clearance by the constitutive androstane receptor (CAR)
Huang, W., Zhang, J., Chua, S. S., Qatanani, M., Han, Y., Granata, R., & Moore, D. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630614100 · Cited by 390
BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis
Edwards, P. A., Kast-Woelbern, H. R., & Anisfeld, A. M. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30180-2 · Cited by 387
Dawson, P. A., Hubbert, M. L., Haywood, J., Craddock, A. L., Zerangue, N., Christian, W. V., & Ballatori, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412752200 · Cited by 381
Zhang, Y., Castellani, L. W., Sinal, C. J., Gonzalez, F. J., & Edwards, P. A. (2004) · Genes & Development · doi:10.1101/gad.1138104 · Cited by 379
Chiang, J. Y. L., Kimmel, R., & Stroup, D. (2001) · Gene · doi:10.1016/s0378-1119(00)00518-7 · Cited by 374
Pascussi, J., Drocourt, L., Fabre, J., Maurel, P., & Vilarem, M. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.2.361 · Cited by 371
Sulfotransferase molecular biology: cDNAs and genes
Weinshilboum, R. M., Otterness, D. M., Aksoy, I. A., Wood, T. C., Her, C., & Raftogianis, R. B. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.1.9034160 · Cited by 369
Xie, W., Yeuh, M.-F., Radominska-p, A., Saini, S. P. S., Negishi, Y., Bottroff, B. S., Cabrera, G. Y., Tukey, R. H., & Evans, R. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438010100 · Cited by 367
Zollner, G. (2001) · Hepatology · doi:10.1053/jhep.2001.22646 · Cited by 359
Self-citationSpontaneous hepatocarcinogenesis in farnesoid X receptor-null mice
Kim, I., Morimura, K., Shah, Y., Yang, Q., Ward, J. M., & Gonzalez, F. J. (2007) · Carcinogenesis · doi:10.1093/carcin/bgl249 · Cited by 357
Orphan Nuclear Receptors as eLiXiRs and FiXeRs of Sterol Metabolism
Lu, T. T., Repa, J. J., & Mangelsdorf, D. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100035200 · Cited by 356
Wagner, M., Halilbasic, E., Marschall, H., Zollner, G., Fickert, P., Langner, C., Zatloukal, K., Denk, H., & Trauner, M. (2005) · Hepatology · doi:10.1002/hep.20784 · Cited by 355
Self-citationYamamoto, Y., Moore, R., Goldsworthy, T. L., Negishi, M., & Maronpot, R. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1459 · Cited by 350
Peroxisome Proliferator–Activated Receptors as Transcriptional Nodal Points and Therapeutic Targets
Brown, J. D., & Plutzky, J. (2007) · Circulation · doi:10.1161/circulationaha.104.475673 · Cited by 345
FXR, a multipurpose nuclear receptor
Lee, F. Y., Lee, H., Hubbert, M. L., Edwards, P. A., & Zhang, Y. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.08.002 · Cited by 344
Zollner, G., Marschall, H., Wagner, M., & Trauner, M. A. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060010s · Cited by 334
Self-citationPascussi, J., Gerbal‐Chaloin, S., Drocourt, L., Maurel, P., & Vilarem, M. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00483-x · Cited by 334
Schuetz, E. G., Strom, S., Yasuda, K., Lecureur, V., Assem, M., Brimer, C., Lamba, J., Kim, R. B., Ramachandran, V., Komoroski, B. J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106340200 · Cited by 334
Regulation ofCYP3AGene Transcription by the Pregnane X Receptor
Goodwin, B. J., Redinbo, M. R., & Kliewer, S. A. (2002) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.111901.111051 · Cited by 328
Prevention of cholesterol gallstone disease by FXR agonists in a mouse model
Moschetta, A., Bookout, A. L., & Mangelsdorf, D. J. (2004) · Nature Medicine · doi:10.1038/nm1138 · Cited by 326
Marschall, H., Wagner, M., Zollner, G., Fickert, P., Diczfalusy, U., Gumhold, J., Silbert, D., Fuchsbichler, A., Benthin, L., Grundström, R., et al. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.009 · Cited by 321
Self-citationLadias, J. A. A., Hadzopoulou‐Cladaras, M., Kardassis, D., Cardot, P., Cheng, J., Zannis, V. I., & Cladaras, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49613-0 · Cited by 319
Fickert, P., Zollner, G., Fuchsbichler, A., Stumptner, C., Weiglein, A. H., Lammert, F., Marschall, H., Tsybrovskyy, O., Zatloukal, K., Denk, H., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.35948 · Cited by 314
Self-citationGuo, G. L., Lambert, G., Negishi, M., Ward, J. M., Brewer, H. B., Kliewer, S. A., Gonzalez, F. J., & Sinal, C. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307145200 · Cited by 312
Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids
Wisely, G. B., Miller, A. B., Davis, R. G., Thornquest, A. D., Johnson, R., Spitzer, T., Sefler, A., Shearer, B., Moore, J. T., Miller, A. B., et al. (2002) · Structure · doi:10.1016/s0969-2126(02)00829-8 · Cited by 311
Lee, Y., Dell, H., Dowhan, D. H., Hadzopoulou‐Cladaras, M., & Moore, D. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.187-195.2000 · Cited by 307
Chiang, J. Y. L., Kimmel, R., Weinberger, C., & Stroup, D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.10918 · Cited by 304
Funk, C., Ponelle, C., Scheuermann, G., & Pantze, M. P. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.3.627 · Cited by 298
Soroka, C. J., Lee, J. M., Azzaroli, F., & Boyer, J. L. (2001) · Hepatology · doi:10.1053/jhep.2001.23501 · Cited by 296
Hepatic Transport of Bile Salts
Kullak-Ublick, G. A., Stieger, B., Hagenbuch, B., & Meier, P. J. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9426 · Cited by 292
Up–Regulation of Basolateral Multidrug Resistance Protein 3 (Mrp3) in Cholestatic Rat Liver
Donner, M. G., & KEPPLER, D. O. R. (2001) · Hepatology · doi:10.1053/jhep.2001.26213 · Cited by 291
Crystal Structure of the HNF4α Ligand Binding Domain in Complex with Endogenous Fatty Acid Ligand
Dhe‐Paganon, S., Duda, K. M., Iwamoto, M. A., Chi, Y., & Shoelson, S. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200420200 · Cited by 291
Plass, J. R. M., Mol, O., Heegsma, J., Geuken, M., Faber, K. N., Jansen, P. L. M., & Müller, M. M. (2002) · Hepatology · doi:10.1053/jhep.2002.31724 · Cited by 291
Huang, W., Zhang, J., Washington, M., Liu, J., Parant, J. M., Lozano, G., & Moore, D. D. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0520 · Cited by 284
Regulation of a xenobiotic sulfonation cascade by nuclear pregnane X receptor (PXR)
Sonoda, J., Xie, W., Rosenfeld, J. M., Barwick, J. L., Guzelian, P. S., & Evans, R. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212494599 · Cited by 281
Nitta, M., Ku, S., Brown, C., Okamoto, A. Y., & Shan, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6660 · Cited by 279
Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis
Zollner, G., Fickert, P., Silbert, D., Fuchsbichler, A., Marschall, H., Zatloukal, K., Denk, H., & Trauner, M. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00096-5 · Cited by 279
Self-citationLaffitte, B. A., Kast-Woelbern, H. R., Nguyen, C., Zavacki, A. M., Moore, D. D., & Edwards, P. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10638 · Cited by 275
Wagner, M., Fickert, P., Zollner, G., Fuchsbichler, A., Silbert, D., Tsybrovskyy, O., Zatloukal, K., Guo, G. L., Schuetz, J. D., Gonzalez, F. J., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01068-0 · Cited by 268
Self-citationHirohashi, T., Suzuki, H., Ito, K., Ogawa, K., Kume, K., Shimizu, T., & Sugiyama, Y. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13278-6 · Cited by 265
Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor.
Staudinger, J. L., Liu, Y., Madan, A., Habeebu, S. S., & Klaassen, C. D. (2001) · PubMed · Cited by 260
Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism
Eloranta, J. J., & Kullak-Ublick, G. A. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.09.019 · Cited by 260
Marschall, H., Wagner, M., Zollner, G., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.009 · Cited by 258
Self-citationFickert, P., Zollner, G., Fuchsbichler, A., Stumptner, C., Pojer, C., Zenz, R., Lammert, F., Stieger, B., Meier, P. J., Zatloukal, K., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.25542 · Cited by 257
Self-citationvan Mil, S. W. C., Milona, A., Dixon, P. H., Müllenbach, R., Geenes, V. L., Chambers, J., Shevchuk, V., Moore, G. E., Lammert, F., Glantz, A., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.015 · Cited by 257
Saini, S. P. S., Sonoda, J., Xu, L., Toma, D., Uppal, H., Mu, Y., Ren, S., Moore, D. D., Evans, R. M., & Xie, W. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.2.292 · Cited by 256
Maher, J. M., Cheng, X., Slitt, A. L., Dieter, M. Z., & Klaassen, C. D. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.003798 · Cited by 255
Transcriptional Regulation of the Human CYP3A4Gene by the Constitutive Androstane Receptor
Goodwin, B. J., Hodgson, E., D'Costa, D. J., et al. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.2.359 · Cited by 254
Characterization of inducible nature of MRP3 in rat liver
Ogawa, K., Suzuki, H. I., Hirohashi, T., et al. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.3.g438 · Cited by 254
Gascon-Barré, M., Demers, C., Mirshahi, A., Néron, S., Zalzal, S., & Nanci, A. (2003) · Hepatology · doi:10.1053/jhep.2003.50176 · Cited by 254
Chen, F., Ma, L., Dawson, P. A., Sinal, C. J., Sehayek, E., Gonzalez, F. J., Breslow, J. L., Ananthanarayanan, M., & Shneider, B. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207903200 · Cited by 253
Farnesoid X Receptor Activates Transcription of the Phospholipid Pump MDR3
Huang, L., Zhao, A., Lew, J.-L., Zhang, T., Hrywna, Y., Thompson, J. R., de Pedro, N., Royo, I., Blevins, R. A., Peláez, F., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308321200 · Cited by 250
Keitel, V., Burdelski, M. M., Warskulat, U., Kühlkamp, T., KEPPLER, D. O. R., Häussinger, D., & Kubitz, R. (2005) · Hepatology · doi:10.1002/hep.20682 · Cited by 249
Leuschner, M., Maier, K., Schlichting, J., Strahl, S., Herrmann, G., Dahm, H. H., Ackermann, H., Happ, J., & Leuschner, U. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70351-3 · Cited by 247
Zhang, J., Huang, W., Qatanani, M., Evans, R. M., & Moore, D. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409041200 · Cited by 246
Transcriptional Regulation of the Human Sterol 12α-Hydroxylase Gene (CYP8B1)
Zhang, M., & Chiang, J. Y. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105117200 · Cited by 244
Assem, M., Schuetz, E. G., Leggas, M. L., Sun, D., Yasuda, K., Reid, G., Zelcer, N., Adachi, M., Strom, S. C., Evans, R. M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314111200 · Cited by 244
Makino, I., HASHIMOTO, H., Shinozaki, K., et al. (1975) · Gastroenterology · doi:10.1016/s0016-5085(75)80094-1 · Cited by 239
Effects of long-term rifampicin administration in primary biliary cirrhosis
Bachs, L., Parés, A., Elena, M., Piera, C., & Rodés, J. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90335-v · Cited by 235
COMPARISON OF RIFAMPICIN WITH PHENOBARBITONE FOR TREATMENT OF PRURITUS IN BILIARY CIRRHOSIS
Bachs, L., Elena, M., Parés, A., Piera, C., & Rodés, J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91608-5 · Cited by 231
A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR
Huang, W., Zhang, J., & Moore, D. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18385 · Cited by 230
Kubitz, R., Wettstein, M., Warskulat, U., & Häussinger, D. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70138-1 · Cited by 228
Moreau, A., Vilarem, M., Maurel, P., & Pascussi, J. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700103m · Cited by 226
Rautiainen, H., Kärkkäinen, P., Karvonen, A., Nurmi, H., Pikkarainen, P., Nuutinen, H., & Färkkilä, M. (2005) · Hepatology · doi:10.1002/hep.20646 · Cited by 222
Landrier, J., Eloranta, J. J., Vavricka, S. R., & Kullak-Ublick, G. A. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00430.2005 · Cited by 221
Zollner, G., & Trauner, M. A. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.11.010 · Cited by 219
Self-citationPost, S. M., Duez, H., Gervois, P. P., Staels, B., Kuipers, F., & Princen, H. M. G. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1101.098228 · Cited by 219
The Farnesoid X Receptor Controls Gene Expression in a Ligand- and Promoter-selective Fashion
Lew, J.-L., Zhao, A., Yu, J., Huang, L., de Pedro, N., Peláez, F., Wright, S. D., & Cui, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306422200 · Cited by 215
Barbier, O., Pineda‐Torra, I., Sirvent, A., Claudel, T., Blanquart, C., Durán-Sandoval, D., Kuipers, F., Kosykh, V., Fruchart, J., & Staels, B. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00388-3 · Cited by 214
Nakata, K., Tanaka, Y., Nakano, T., Adachi, T., Tanaka, H., Kaminuma, T., & Ishikawa, T. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.437 · Cited by 213
Cherrington, N. J., Hartley, D. P., Li, N., Johnson, D. R., & Klaassen, C. D. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.1.97 · Cited by 212
Li, T., & Chiang, J. Y. L. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00258.2004 · Cited by 212
Fabiani, E. D., Mitro, N., Gilardi, F., Caruso, D., Galli, G., & Crestani, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305079200 · Cited by 210
Dehydroepiandrosterone Sulfotransferase Gene Induction by Bile Acid Activated Farnesoid X Receptor
Song, C. S., Echchgadda, I., Baek, B. S., Ahn, S., Oh, T., Roy, A. K., & Chatterjee, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107557200 · Cited by 208
Modulation of human nuclear receptor LRH-1 activity by phospholipids and SHP
Ortlund, E. A., Lee, Y., Solomon, I. H., Hager, J., Safi, R., Choi, Y., Guan, Z., Tripathy, A., Raetz, C. R. H., McDonnell, D. P., et al. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb910 · Cited by 203
Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis
Prince, M. I., Burt, A. D., & Jones, D. E. J. (2002) · Gut · doi:10.1136/gut.50.3.436 · Cited by 202
Dubuquoy, L., Dharancy, S., Nutten, S., Pettersson, S., Auwerx, J. H., & Desreumaux, P. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11395-x · Cited by 201
A controlled trial of prednisolone treatment in primary biliary cirrhosis
Mitchison, H. C., Palmer, J. M., Bassendine, M. F., Watson, A. J., Record, C. O., & James, O. (1992) · Journal of Hepatology · doi:10.1016/0168-8278(92)90065-w · Cited by 199
Fiorucci, S., Clerici, C., Antonelli, E., Orlandi, S., Goodwin, B. J., Sadeghpour, B. M., Sabatino, G., Russo, G., Castellani, D., Willson, T. M., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.079665 · Cited by 199
Zollner, G., Fickert, P., Fuchsbichler, A., Silbert, D., Wagner, M., Arbeiter, S., Gonzalez, F. J., Marschall, H., Zatloukal, K., Denk, H., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00228-9 · Cited by 198
Self-citationDifferential Regulation of Rat and HumanCYP7A1by the Nuclear Oxysterol Receptor Liver X Receptor-α
Goodwin, B. J., Watson, M. A., Kim, H., Miao, J., Kemper, J. K., & Kliewer, S. A. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0246 · Cited by 196
Nuclear Receptors and Drug Disposition Gene Regulation
Tirona, R. G., & Kim, R. B. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20324 · Cited by 194
A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR
Huang, W., Zhang, J., & Moore, D. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200418385 · Cited by 193
Hepatocyte Nuclear Factor 1α: A Key Mediator of the Effect of Bile Acids on Gene Expression
Jung, D., & Kullak-Ublick, G. A. (2003) · Hepatology · doi:10.1053/jhep.2003.50100 · Cited by 192
Chen, F. Y., Ananthanarayanan, M., Emre, S., Neimark, E., Bull, L. N., Knisely, A. S., Strautnieks, S. S., Thompson, R. J., Magid, M. S., Gordon, R. D., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.013 · Cited by 191
Squires, E. J., Sueyoshi, T., & Negishi, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407281200 · Cited by 188
Jung, D., Fantin, A. C., Scheurer, U., Fried, M., & Kullak-Ublick, G. A. (2003) · Gut · doi:10.1136/gut.53.1.78 · Cited by 188
Tian, J. M., & Schibler, U. (1991) · Genes & Development · doi:10.1101/gad.5.12a.2225 · Cited by 186
Marrapodi, M., & Chiang, J. Y. L. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32398-1 · Cited by 185
Fabiani, E. D., Mitro, N., Anzulovich, A. C., Pinelli, A., Galli, G., & Crestani, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103270200 · Cited by 184
Fiorucci, S., Rizzo, G., Antonelli, E., Renga, B., Mencarelli, A., Riccardi, L., Orlandi, S., Pruzanski, M., Morelli, A., & Pellicciari, R. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084905 · Cited by 183
FXR regulates organic solute transporters α and β in the adrenal gland, kidney, and intestine
Lee, H. C., Zhang, Y., Lee, F. Y., Nelson, S. F., Gonzalez, F. J., & Edwards, P. A. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500417-jlr200 · Cited by 180
Szatmári, I., Vámosi, G., Brázda, P., Bálint, B. L., Benkő, S., Széles, L., Jeney, V., Özvegy‐Laczka, C., Szántó, A., Barta, E., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604890200 · Cited by 180
Zollner, G., Wagner, M., Moustafa, T., Fickert, P., Silbert, D., Gumhold, J., Fuchsbichler, A., Halilbasic, E., Denk, H., Marschall, H., et al. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00490.2005 · Cited by 180
Self-citationRegulation of CYP3A4 by the bile acid receptor FXR
Gnerre, C., ttler, S. B., Kaufmann, M., Looser, R., & Meyer, U. (2004) · Pharmacogenetics · doi:10.1097/00008571-200410000-00001 · Cited by 178
Fiorucci, S., Rizzo, G., Antonelli, E., Renga, B., Mencarelli, A., Riccardi, L., Morelli, A., Pruzanski, M., & Pellicciari, R. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085597 · Cited by 177
The Involvement of the Pregnane X Receptor in Hepatic Gene Regulation during Inflammation in Mice
Teng, S., & Piquette‐Miller, M. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.076141 · Cited by 175
Nuclear receptor regulation of hepatic function
Karpen, S. J. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00129-0 · Cited by 173
Sulphated and unsulphated bile acids in serum, bile, and urine of patients with cholestasis.
Henegouwen, G. P. V. B., Brandt, K. H., Eyssen, H., & Parmentier, G. G. (1976) · Gut · doi:10.1136/gut.17.11.861 · Cited by 172
Benefit of farnesoid X receptor inhibition in obstructive cholestasis
Stedman, C. A. M., Liddle, C., Coulter, S., Sonoda, J., Alvarez, J. G. A., Evans, R. M., & Downes, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604772103 · Cited by 171
Jung, D., Fantin, A. C., Scheurer, U., Fried, M., & Kullak-Ublick, G. A. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)80515-2 · Cited by 170
Pineda‐Torra, I., Jamshidi, Y., Flavell, D. M., Fruchart, J., & Staels, B. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.5.0833 · Cited by 169
Takeda, K., Ichiki, T., Tokunou, T., Funakoshi, Y., Iino, N., Hirano, K., Kanaide, H., & Takeshita, A. (2000) · Circulation · doi:10.1161/01.cir.102.15.1834 · Cited by 168
Kok, T., Bloks, V. W., Wolters, H., Havinga, R., Jansen, P. L. M., Staels, B., & Kuipers, F. (2003) · Biochemical Journal · doi:10.1042/bj20020981 · Cited by 161
Hepatocanalicular Transport Defects: Pathophysiologic Mechanisms of Rare Diseases
Elferink, R. P. J. O., Paulusma, C. C., & Groen, A. K. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.08.052 · Cited by 159
Repression of Farnesoid X Receptor during the Acute Phase Response
Kim, M. S., Shigenaga, J. K., Moser, A., Feingold, K. R., & Grünfeld, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212633200 · Cited by 157
Echchgadda, I., Song, C. S., Roy, A. K., & Chatterjee, B. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.720 · Cited by 156
Lee, Y.-K., Schmidt, D. R., Cummins, C. L., Choi, M., Peng, L., Zhang, Y., Goodwin, B. J., Hammer, R. E., Mangelsdorf, D. J., & Kliewer, S. A. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0565 · Cited by 154
Araya, Z., & Wikvall, K. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00031-1 · Cited by 154
Bile acid profiles in urine of patients with liver diseases
Bremmelgaard, A., & Sjövall, J. (1979) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1979.tb00894.x · Cited by 153
Ding, X., Lichti-Kaiser, K., Kim, I., Gonzalez, F. J., & Staudinger, J. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600931200 · Cited by 153
Activation of LXRs prevents bile acid toxicity and cholestasis in female mice
Uppal, H., Saini, S. P. S., Moschetta, A., Mu, Y., Zhou, J., Gong, H., Zhai, Y., Ren, S., Michalopoulos, G. K., Mangelsdorf, D. J., et al. (2007) · Hepatology · doi:10.1002/hep.21494 · Cited by 151
Bohan, A., Chen, W., Denson, L. A., Held, M. A., & Boyer, J. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304011200 · Cited by 151
Mataki, C., Magnier, B. C., Houten, S. M., Annicotte, J., Argmann, C., Thomas, C., Overmars, H., Kulik, W., METZGER, D., Auwerx, J. H., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00852-07 · Cited by 148
INDUCTION OF ABCC3 (MRP3) BY PREGNANE X RECEPTOR ACTIVATORS
Teng, S., Jekerle, V., & Piquette‐Miller, M. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.11.1296 · Cited by 148
Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7
Gall, W. E., Zawada, G., Mojarrabi, B., Tephly, T. R., Green, M. D., Coffman, B. L., Mackenzie, P. I., & Radominska-p, A. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00088-6 · Cited by 145
The crystal structures of human steroidogenic factor-1 and liver receptor homologue-1
Wang, W., Zhang, C., Marimuthu, A., Krupka, H. I., Tabrizizad, M., Shellooe, R., Mehra, U., Eng, K., Nguyen, H. T., Settachatgul, C., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409482102 · Cited by 145
Barbier, O., Durán-Sandoval, D., Pineda‐Torra, I., Kosykh, V., Fruchart, J., & Staels, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305361200 · Cited by 144
Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse
José Chianale, B., Vollrath, V., Wielandt, A. M., Amigo, L., Rigotti, A., Nervi, F. O., González, S., ANDRADE, L., Pizarro, M., & Luigi Accatino, L. (1996) · Biochemical Journal · doi:10.1042/bj3140781 · Cited by 143
Abnormal expression of anion exchanger genes in primary biliary cirrhosis
Prìeto, J., Qian, C., García, N., Díez, J., & Medina, J. F. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90735-u · Cited by 141
Novel pathways of bile acid metabolism involving CYP3A4
Bodin, K., Lindbom, U., & Diczfalusy, U. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.11.003 · Cited by 141
Miura, T., Ouchida, R., Yoshikawa, N., Okamoto, K., Makino, Y., Nakamura, T., Morimoto, C., Makino, I., & Tanaka, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107098200 · Cited by 137
Kamiya, A., Inoue, Y., & Gonzalez, F. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50212 · Cited by 136
Ghose, R., Zimmerman, T. L., Thevananther, S., & Karpen, S. J. (2004) · Nuclear Receptor · doi:10.1186/1478-1336-2-4 · Cited by 135
Hepatoprotective role of PXR activation and MRP3 in cholic acid‐induced cholestasis
Teng, S., & Piquette‐Miller, M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707235 · Cited by 134
Miquerol, L., López, S., Cartier, N., Tulliez, M., Raymondjean, M., & Kahn, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37059-x · Cited by 133
del Castillo‐Olivares, A., & Gil, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000996200 · Cited by 133
Eloranta, J. J., Jung, D., & Kullak-Ublick, G. A. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0159 · Cited by 131
Bezafibrate treatment: a new medical approach for PBC patients?
Kanda, T., Yokosuka, O., Imazeki, F., & Saisho, H. (2003) · Journal of Gastroenterology · doi:10.1007/s00535-002-1102-7 · Cited by 129
Zollner, G., Wagner, M., Fickert, P., Silbert, D., Gumhold, J., Zatloukal, K., Denk, H., & Trauner, M. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01506.x · Cited by 128
Self-citationKarpen, S. J., Sun, A., Kudish, B., Hagenbuch, B., Meier, P. J., Ananthanarayanan, M., & Suchy, F. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15211 · Cited by 128
Farnesoid X Receptor: From Structure to Potential Clinical Applications
Pellicciari, R., Costantino, G., & Fiorucci, S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0582221 · Cited by 128
Bremmelgaard, A., & Sjövall, J. (1980) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34768-4 · Cited by 127
Almé, B., & Sjövall, J. (1980) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(80)90164-8 · Cited by 126
Selective activation of liver X receptor alpha by 6α-hydroxy bile acids and analogs
Song, C. (2000) · Steroids · doi:10.1016/s0039-128x(00)00127-6 · Cited by 126
Falkner, K. C., Pinaire, J. A., Xiao, G., Geoghegan, T. E., & Prough, R. A. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12625-9 · Cited by 126
Research works printed but not linked: 1
- Kamisako T, 1995, Marked improvement in cholestasis and hypercholesterolemia with simvastatin in a patient with primary biliary cirrhosis, Am J Gastroenterol, 90, 1187
Cited by
Sorted by citations
Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
Jia, W., Xie, G., & Jia, W. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.119 · Cited by 1,924
Bile acid signaling in metabolic disease and drug therapy
Li, T., & Chiang, J. Y. L. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008201 · Cited by 935
New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond
Beuers, U., Trauner, M., Jansen, P., & Poupon, R. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.023 · Cited by 537
Self-citationNovel therapeutic targets for cholestatic and fatty liver disease
Trauner, M., & Fuchs, C. D. (2022) · Gut · doi:10.1136/gutjnl-2021-324305 · Cited by 204
Self-citationThe challenges of primary biliary cholangitis: What is new and what needs to be done
Terziroli Beretta-Piccoli, B., Mieli-Vergani, G., Vergani, D., Vierling, J. M., Adams, D., Alpini, G., Banales, J. M., Beuers, U., Björnsson, E., Bowlus, C., et al. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102328 · Cited by 114
Self-citation
Metadata
- Authors
- Zollner, G., & Trauner, M.
- Affiliations
- Medical University of Graz (AT)
- Corresponding author
- Trauner, Michael
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2008-12-24
- Volume
- 156
- Issue
- 1
- Pages
- 7-27
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC2697779
- OpenAlex
- W2022838513
- Cited by
- 146
- References
- 304
- Citations by year
- 2026: 6 · 2025: 2 · 2024: 6 · 2023: 4 · 2022: 11 · 2021: 4 · 2020: 7 · 2019: 7 · 2018: 6 · 2017: 6 · 2016: 11 · 2015: 7 · 2014: 14 · 2013: 12 · 2012: 9
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- nuclear receptors, cholestasis, cholestatic liver injury, farnesoid X receptor, pregnane X receptor, vitamin D receptor, constitutive androstane receptor, bile acid metabolism, bile acid transport, bile acid detoxification, hepatoprotection, liver fibrosis, liver cirrhosis, nuclear receptor agonists, ursodeoxycholic acid, pruritus, liver inflammation
- MeSH terms
- Bile Acids and Salts, Cholestasis, Chronic Disease, Humans, Ligands, Liver, Liver Cirrhosis, Receptors, Cytoplasmic and Nuclear
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review